TBI

Filter Your Results

 

News

 

Blood Test for TBI Licensed for Use and Development on Abbot Laboratory Instruments

Thursday, April 18, 2019—A Food and Drug Administration (FDA) approved blood test for mild traumatic brain injury (mTBI), also known as concussion, may become more widely available soon. The blood tes…

FDA Warns About Unapproved Devices for Diagnosing and Treating Concussion

Thursday, April 11, 2019—The Food and Drug Administration (FDA) has issued a warning regarding tools being marketed for assessing, diagnosing, or managing concussion that are not FDA-approved. The FDA…

Database of Eye-Tracking Movements Could Aid Diagnosis and Treatment

Wednesday, April 03, 2019—Eye-tracking technology (Brain Health EyeQ; RightEye, Bethesda, MD) that captures data on people’s eye movements has been used to produce a database of 1 billion data po…

First US Clinical Trial of Cannabinoid Supplements for Traumatic Brain Injury

Thursday, February 21, 2019—The first clinical study (NCT03826368) in the US to assess the effectiveness of plant-derived cannabinoid supplements for recovery from traumatic brain injury will begin in Co…

Premarket Clearance Request Filed for Robotic Neurovascular Intervention

Friday, February 15, 2019—A premarket clearance request for a neurovascular intervention platform (CorPath GRX System; Corindus Vascular Robotics, Waltham, MA) has been filed with the Food and Drug Adm…

Study Shows That Learning Processes May Determine Severity of PTSD Symptoms

Friday, February 08, 2019—Findings from a study published in Nature Neurosciencereveal distinct patterns for how the brain and body respond when learning about danger and safety. The findings coul…

Risk of Mood and Posttraumatic Stress Disorders Increased 3 and 6 Months After Concussion

Thursday, February 07, 2019—Results from the TRACK-TBI study (NCT02119182), recently published in JAMA Psychiatry show that approximately 1 in 5 individuals who have mild traumatic brain injury…

Eye-Movement Tracker Approved for Diagnosing Concussion

Thursday, January 10, 2019—The Food and Drug Administration has granted a de novo request for marketing authorization of an algorithm-driven eye-movement tracking system (Eyebox; Oculogica, New York, NY…

 
 

Contact Info

For advertising rates and opportunities:
Wendy Terry
Publisher
217-652-3859
wterry@bmctoday.com

About Practical Neurology

Launched in 2002, Practical Neurology is a publication uniquely dedicated to presenting current approaches to patient management, synthesis of emerging research and data, and analysis of industry news with a goal to facilitate practical application and improved clinical practice for all neurologists. Our straightforward articles give neurologists tools they can immediately put into practice.

 
  • BRYN MAWR COMMUNICATIONS III, LLC